SIR2 regulation

Details for Australian Patent Application No. 2004264851 (hide)

Owner Albert Einstein College of Medicine of Yeshiva University

Inventors Schram, Vern L.; Sauve, Anthony A.

Agent Shelston IP

Pub. Number AU-A-2004264851

PCT Pub. Number WO2005/016342

Priority 60/484,321 02.07.03 US

Filing date 30 June 2004

Wipo publication date 24 February 2005

International Classifications

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/016342 Priority application(s): WO2005/016342

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004264853-A novel antiproliferative factor and methods of use

2004264850-Antimicrobial compositions including carboxylic acids and alkoxylated amines